GlaxoSmithKline Plc's (GSK) sales in China jumped 20 percent to about 1 billion pounds ($1.5 billion) last year, almost quadruple the pace of growth across its emerging markets. Police say bribes and sexual favors spurred the gain.
http://is.gd/gBxwfG
Sent via BlackBerry by Union Paradise
Russia’s New Car Market Shrinks in 2025 as Chinese Brands Lose Ground
-
Russia's market for new passenger cars declined noticeably in 2025,
reflecting broader structural changes in supply, consumer demand, and
import dynamics. ...
No comments:
Post a Comment